Maja Bergman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maja Bergman has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Amit Lazarov
School of Psychological Sciences, Tel Aviv University, Tel-Aviv, Israel
3 shared publications - Doron Amsalem
New York State Psychiatric Institute and Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York
3 shared publications Alexandra Klein Rafaeli
Psychological Services, Ben Gurion University of the Negev, Be'er Sheva, Israel
1 shared publicationAlison M. Pickover
New York State Psychiatric Institute
1 shared publication- Andrea Lopez-Yianilos
New York State Psychiatric Institute
1 shared publication - Andrés Martin
Child Study Center, Yale School of Medicine, New Haven, USA
1 shared publication
Latest Publications
- 20 November 2024
- Published by Elsevier in Psychiatry Research
- Vol. 343, 116280
Brief video intervention to increase treatment-seeking among individuals living in a conflict zone: A randomized controlled trial
- 20 November 2024
- Published by Elsevier in Psychiatry Research
- Vol. 343, 116280
Brief video intervention to increase treatment-seeking among individuals living in a conflict zone: A randomized controlled trial
- Open Access
- 10 July 2024
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 15 (1) , 2370174
Self-stigma mediates the relationships between childhood maltreatment and symptom levels of PTSD, depression, and anxiety
Background: Childhood maltreatment is a risk factor for developing multiple forms of psychopathology, including depression, posttraumatic stress disorder (PTSD), and anxiety. Yet, the mechanisms linking childhood maltreatment and these psychopathologies remain less clear.Objective: Here we examined whether self-stigma, the internalization of negative stereotypes about one's experiences, mediates the relationship between childhood maltreatment and symptom severity of depression, PTSD, and anxiety.Methods: Childhood trauma survivors (N = 685, Mage = 36.8) were assessed for childhood maltreatment, self-stigma, and symptoms of depression, PTSD, and anxiety. We used mediation analyses with childhood maltreatment as the independent variable. We then repeated these mediation models separately for childhood abuse and neglect, as well as the different subtypes of childhood maltreatment.Results: Self-stigma significantly mediated the relationship between childhood maltreatment and depression, PTSD, and anxiety symptoms. For sexual abuse - but not physical or emotional abuse - a significant mediation effect of self-stigma emerged on all symptom types. For childhood neglect, self-stigma significantly mediated the relationship between both emotional and physical neglect and all symptom types.Conclusion: Our cross-sectional study suggests that different types of childhood maltreatment experiences may relate to distinct mental health problems, potentially linked to increased self-stigma. Self-stigma may serve as an important treatment target for survivors of childhood abuse and neglect.
- 10 July 2024
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 15 (1) , 2370174
Open AccessSelf-stigma mediates the relationships between childhood maltreatment and symptom levels of PTSD, depression, and anxiety
Background: Childhood maltreatment is a risk factor for developing multiple forms of psychopathology, including depression, posttraumatic stress disorder (PTSD), and anxiety. Yet, the mechanisms linking childhood maltreatment and these psychopathologies remain less clear.Objective: Here we examined whether self-stigma, the internalization of negative stereotypes about one's experiences, mediates the relationship between childhood maltreatment and symptom severity of depression, PTSD, and anxiety.Methods: Childhood trauma survivors (N = 685, Mage = 36.8) were assessed for childhood maltreatment, self-stigma, and symptoms of depression, PTSD, and anxiety. We used mediation analyses with childhood maltreatment as the independent variable. We then repeated these mediation models separately for childhood abuse and neglect, as well as the different subtypes of childhood maltreatment.Results: Self-stigma significantly mediated the relationship between childhood maltreatment and depression, PTSD, and anxiety symptoms. For sexual abuse - but not physical or emotional abuse - a significant mediation effect of self-stigma emerged on all symptom types. For childhood neglect, self-stigma significantly mediated the relationship between both emotional and physical neglect and all symptom types.Conclusion: Our cross-sectional study suggests that different types of childhood maltreatment experiences may relate to distinct mental health problems, potentially linked to increased self-stigma. Self-stigma may serve as an important treatment target for survivors of childhood abuse and neglect.
- 16 September 2021
- Published by American Psychological Association (APA) in Psychological Trauma: Theory, Research, Practice, and Policy
- Vol. 14 (4) , 578-586
Treatment dropout among veterans and their families: Quantitative and qualitative findings.
Clinical Impact Statement The findings of this study have the potential to improve clinical care for veterans and family members in a number of ways. For example, providing nonexposure-based interventions to veterans, particularly to depressed patients, may reduce dropouts, and facilitate treatment completion. Furthermore, the findings suggest that openly discussing difficulties to continue treatment among patients who might consider dropping out, may lower dropout rates. Background: Psychotherapy noncompletion rates for veterans and their families are high. This study sought to (a) measure noncompletion rates of such patients at a university-based treatment center, (b) compare veteran and family member attrition rates, (c) identify dropout predictors, and (d) explore clinicians' perspectives on treatment noncompletion. Method: Using quantitative and qualitative approaches, we analyzed demographic and clinical characteristics of 141 patients (90 military veterans; 51 family members) in a university treatment center. We defined dropout as not completing the time-limited therapy contract. Reviewing semistructured interview data assessing clinicians' perspectives on their patients' dropout, three independent raters agreed on key themes, with interrater coefficient kappa range .74 to 1. Results: Patient attrition was 24%, not differing significantly between veterans and family members. Diagnosis of major depression (MDD) and exposure-based therapies predicted noncompletion, as did higher baseline Hamilton Depression Rating Scale (HDRS) total scores, severe depression (HDRS > 20), lack of Beck Depression Inventory weekly improvement, and history of military sexual trauma. Clinicians mostly attributed noncompletion to patient difficulties coping with intense emotions, especially in exposure-based therapies. Conclusion: Noncompletion rate at this study appeared relatively low compared to other veteran-based treatment centers, if still unfortunately substantial. Patients with comorbid MDD/PTSD and exposure-based therapies carried greater noncompletion risk due to the MDD component, and this should be considered in treatment planning. Ongoing discussion of dissatisfaction and patient discontinuation, in the context of a strong therapeutic alliance, might reduce noncompletion in this at-risk population.
- 16 September 2021
- Published by American Psychological Association (APA) in Psychological Trauma: Theory, Research, Practice, and Policy
- Vol. 14 (4) , 578-586
Treatment dropout among veterans and their families: Quantitative and qualitative findings.
Clinical Impact Statement The findings of this study have the potential to improve clinical care for veterans and family members in a number of ways. For example, providing nonexposure-based interventions to veterans, particularly to depressed patients, may reduce dropouts, and facilitate treatment completion. Furthermore, the findings suggest that openly discussing difficulties to continue treatment among patients who might consider dropping out, may lower dropout rates. Background: Psychotherapy noncompletion rates for veterans and their families are high. This study sought to (a) measure noncompletion rates of such patients at a university-based treatment center, (b) compare veteran and family member attrition rates, (c) identify dropout predictors, and (d) explore clinicians' perspectives on treatment noncompletion. Method: Using quantitative and qualitative approaches, we analyzed demographic and clinical characteristics of 141 patients (90 military veterans; 51 family members) in a university treatment center. We defined dropout as not completing the time-limited therapy contract. Reviewing semistructured interview data assessing clinicians' perspectives on their patients' dropout, three independent raters agreed on key themes, with interrater coefficient kappa range .74 to 1. Results: Patient attrition was 24%, not differing significantly between veterans and family members. Diagnosis of major depression (MDD) and exposure-based therapies predicted noncompletion, as did higher baseline Hamilton Depression Rating Scale (HDRS) total scores, severe depression (HDRS > 20), lack of Beck Depression Inventory weekly improvement, and history of military sexual trauma. Clinicians mostly attributed noncompletion to patient difficulties coping with intense emotions, especially in exposure-based therapies. Conclusion: Noncompletion rate at this study appeared relatively low compared to other veteran-based treatment centers, if still unfortunately substantial. Patients with comorbid MDD/PTSD and exposure-based therapies carried greater noncompletion risk due to the MDD component, and this should be considered in treatment planning. Ongoing discussion of dissatisfaction and patient discontinuation, in the context of a strong therapeutic alliance, might reduce noncompletion in this at-risk population.